This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DDDD
4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de 4D pharma plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.17 |
| 52 Week High | UK£0.77 |
| 52 Week Low | UK£0.14 |
| Beta | 2.74 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -54.42% |
| 3 Year Change | -83.26% |
| 5 Year Change | -92.83% |
| Change since IPO | -90.34% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| DDDD | GB Biotechs | Mercado GB | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.1% |
| 1Y | -54.4% | -25.7% | 1.9% |
Rentabilidad vs. Industria: DDDD underperformed the UK Biotechs industry which returned -24.7% over the past year.
Rentabilidad vs. Mercado: DDDD underperformed the UK Market which returned -3.7% over the past year.
Volatilidad de los precios
| DDDD volatility | |
|---|---|
| DDDD Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: DDDD has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine DDDD's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2014 | 106 | Duncan Peyton | www.4dpharmaplc.com |
Resumen de fundamentos de 4D pharma plc
| Estadísticas fundamentales de DDDD | |
|---|---|
| Capitalización bursátil | UK£30.04m |
| Beneficios(TTM) | -UK£26.50m |
| Ingresos (TTM) | UK£595.83k |
50.4x
Ratio precio-ventas (PS)-1.1x
Ratio precio-beneficio (PE)¿Está DDDD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DDDD | |
|---|---|
| Ingresos | US$718.00k |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$718.00k |
| Otros gastos | US$32.66m |
| Beneficios | -US$31.94m |
Últimos beneficios comunicados
Dec 31, 2021
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.18 |
| Margen bruto | 100.00% |
| Margen de beneficio neto | -4,448.19% |
| Ratio deuda/patrimonio | 36.5% |
¿Cómo se ha desempeñado DDDD a largo plazo?
Ver rendimiento histórico y comparativa